Skip to content
GenoLensGenoLens

ASNS

Chr 7q21.3

asparagine synthetase (glutamine-hydrolyzing)

MANE:
ENST00000394308.8

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Early onset or syndromic epilepsy

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome

    0.81
  • Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome

    0.81
  • hereditary disease

    0.47
  • Neurodevelopmental delay

    0.43
  • Abnormal cerebral morphology

    0.35
  • Neurodevelopmental abnormality

    0.29
  • cholelithiasis

    0.28
  • spinocerebellar ataxia, autosomal recessive 29

    0.27
  • multiple sclerosis

    0.22
  • colorectal carcinoma

    0.10

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.